Natalizumab adverse events are rare in patients with multiple sclerosis. Fragoso Y D, Alves-Leon S V, Arruda W O, de Carvalho M J, Comini-Frota E R, Corrêa E C, Ferreira M L B, da Gama P D, Gomes S, Gonçalves M V M, et al. Arq Neuropsiquiatr. 2013 Mar; 71(3):137-41. PMID: 23563711. Abstract CommentRecommendBookmarkWatch